Full Text View
Tabular View
No Study Results Posted
Related Studies
Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection (PREDICT)
This study is not yet open for participant recruitment.
Verified July 2010 by Health Protection Agency, United Kingdom
Study NCT01162265   Information provided by Health Protection Agency, United Kingdom

First Received on July 12, 2010.   Last Updated on July 13, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tuberculsosis
IGRA
Additional conditions recognized in this trial
Latent Tuberculosis
Tuberculosis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Mycobacterium Infections
Additional drug interventions recognized in this trial
Interferon-gamma
Interferons
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Health Protection Agency, United Kingdom
Imperial College London
Queen Mary University of London
University College, London
Brunel University
University of Birmingham


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services